News Releases

July 2021

July 28, 2021 7/28/2021 U.S. Food and Drug Administration Grants Breakthrough Therapy Designation

July 26, 2021 7/26/2021 Takeda to Hold First Quarter FY2021 Earnings Conference Calls

July 20, 2021 7/20/2021 Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders

July 20, 2021 7/20/2021 Takeda Expands Moderna’s COVID-19 Vaccine Supply in Japan in Partnership with the Japanese Government

July 19, 2021 7/19/2021 Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock Exchange

July 9, 2021 7/9/2021 New Data from the Phase 3 HELP Study™: Safety and Efficacy of TAKHZYRO®

July 8, 2021 7/8/2021 Notice Concerning Issuance of New Shares under the Long-Term Incentive Plan for Company Group Employees Overseas

June 2021

June 29, 2021 6/29/2021 Takeda Announces the Publication of its Annual Report on Form 20-F for FY2020

June 29, 2021 6/29/2021 Notice Concerning Withdrawal of Shelf Registration Statement and Filing of New Shelf Registration Statement in Japan for the Issuance of New Shares